Dr Rosa Moreira is co-founder and CEO of Experian, a research and consulting firm bringing together experts in health and engineering. With a decades long career in the health sector, she followed her education in Nursing, with a post-graduation in Nursing management and administration, a Master in Psychiatry and Mental Health, and a PhD in Biomedical Sciences. She has co-authored 2 books, more than 35 scientific publications in international peer-reviewed journals and conferences, and is a regular participant in continuous education training (on research methodologies, data analysis, information technologies, performance evaluation, communication and conflict management, auditing techniques and management in health). At Experian, Dr Moreira builds on her experience to support the management of the EU projects, support the technical research and development activities, and contribute to the dissemination and communication efforts.
Ms Daniela Moreira is the CFO at Experian. With a major in Economics from Minho University, an MBA in Corporate Finance from Atlantic Business School, a Master in Services Management from Porto University, she is Member of the Portuguese Economists Association, and a Certified Accountant from the Portuguese Accountants Association. With more than 20 years of professional experience, she is certified in Leadership and Management, and in Communication and Interpersonal relations by the Carnegie University (New York). Having developed and managed dozens of projects involving entrepreneurship, innovation, and internationalization, she regularly serves as evaluator of entrepreneurship projects. At Experian, she oversees the financial management of the EU projects, and supports the technical and management teams, to ensure a timely implementation of the planned activities
Fabian was born and raised in the beautiful northern German city of Hamburg. Curious about the country of chocolate and mountains, he attended ETH Zurich, where he received his B.Sc. and M.Sc. in Mechanical engineering. During this time, he did a six-month internship at Evonik in the field of semiconductors in Hsinchu, Taiwan.
During his studies, he developed a keen interest in scaling phenomena and small-scale robots. For his Master's thesis, he joined the Harvard Microrobotics Laboratory, where he developed electroadhesive devices that enable small-scale robots to walk and climb on inclined and vertical surfaces.
Trading the Boston clam chowder for Swiss Raclette, he joined MSRL as a doctoral student in August 2019. His research puts a spotlight on the development, fabrication, and manipulation of small-scale robots for minimally invasive surgery and drug delivery. Within ANGIE, Fabian coordinates the development and manufacture of the drug delivery platform.
Outside the lab, he enjoys road biking, exploring the Swiss mountains, and the occasional glass of wine.
Lukas Hertle (1994) grew up in Germany, he graduated from high school in Scotland where he received an academic scholarship. He moved to Switzerland in 2014 to study mechanical engineering at the Swiss Federal Institute of Technology (ETH Zurich). During his bachelor studies, his primary focus was on micro- and nano-systems and he undertook research studies on the synthesis of biodegradable polymer-nanoparticle composites, completing his studies with a bachelor thesis on the usage of hydrogel-magnetic nanoparticle composites in microrobots.
After finishing his bachelor’s degree, he continued studying at ETH Zurich concentrating on the field of robotics and nano-systems for biomedical applications. He started working at the MSRL during his semester thesis, which was on the fabrication of biocompatible magnetic nanoparticles, proceeding later in this field by writing his master’s thesis on the synthesis and functionalization of high-performance magnetic nanoparticles for use in microrobotic devices.
In August 2021, he joined the Multi-Scale Robotics Lab as a PhD student and is currently working on the development of microfluidic-assisted fabrication of novel soft microrobots for biomedical applications.